Non-Immigrant Admissions to the US, and More from CRS
There were 181.3 million foreign nationals who were admitted to the United States on a temporary basis in FY 2016 for reasons such as business or tourism.
A new report from the Congressional Research Service “explains the statutory and regulatory provisions that govern nonimmigrant admissions to the United States [and] describes trends in temporary migration, including changes over time in the number of nonimmigrant visas issued and nonimmigrant admissions.” See Nonimmigrant (Temporary) Admissions to the United States: Policy and Trends, December 8, 2017.
Other new and updated reports from the Congressional Research Service include the following.
Supreme Court Declines to Take Up Military Commission Challenges — Al Bahlul and Al-Nashiri, CRS Legal Sidebar, December 12, 2017
A Shift in the International Security Environment: Potential Implications for Defense–Issues for Congress, updated December 12, 2017
Venezuela: Background and U.S. Policy, updated December 11, 2017
Jerusalem: U.S. Recognition as Israel’s Capital and Planned Embassy Move, CRS Insight, December 8, 2017
Taylor Force Act: Palestinian Terrorism-Related Payments and U.S. Aid, CRS Insight, updated December 12, 2017
Suing Subway: When Does a Class Action Settlement Benefit Only the Lawyers?, CRS Legal Sidebar, December 12, 2017
Navy Aegis Ballistic Missile Defense (BMD) Program: Background and Issues for Congress, updated December 8, 2017
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.